FDA Clears Hypertension Drug for Youngsters

Well, this is sad.

The FDA has approved the antihypertensive olmesartan (Benicar) for patients ages 6 to 16, manufacturer Daiichi Sankyo announced.

Kudos, fatsos.

You have made your kids sick fat people.

Adverse reactions include back pain, bronchitis, increased creatine phosphokinase, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Plainly and simply, you are disgusting nutritional child abusers.